TRIM47 accelerates aerobic glycolysis and tumor progression through regulating ubiquitination of FBP1 in pancreatic cancer

L Li, Y Yu, Z Zhang, Y Guo, T Yin, H Wu… - Pharmacological …, 2021 - Elsevier
L Li, Y Yu, Z Zhang, Y Guo, T Yin, H Wu, M Yang
Pharmacological Research, 2021Elsevier
Increasing studies demonstrated that ubiquitination plays a vital role in the pathogenesis of
pancreatic cancer, and targeting regulation of the ubiquitination process is a potential
means for cancer treatment. However, the role of tripartite motif 47 (TRIM47) in pancreatic
cancer is still unclear. Here, significantly upregulated TRIM47 and decreased FBP1
expressions were found in pancreatic cancer patient tissues and pointed to a lower survival
rate. In addition, we show that TRIM47 was upregulated in pancreatic cancer cells and …
Abstract
Increasing studies demonstrated that ubiquitination plays a vital role in the pathogenesis of pancreatic cancer, and targeting regulation of the ubiquitination process is a potential means for cancer treatment. However, the role of tripartite motif 47 (TRIM47) in pancreatic cancer is still unclear. Here, significantly upregulated TRIM47 and decreased FBP1 expressions were found in pancreatic cancer patient tissues and pointed to a lower survival rate. In addition, we show that TRIM47 was upregulated in pancreatic cancer cells and promoted cell proliferation in vitro and in vivo. Mechanistic investigations showed that TRIM47 promoted the aerobic glycolysis of pancreatic cancer cells, which was largely dependent on the direct binding to and ubiquitination of fructose-1, 6-biphosphatase (FBP1). Furthermore, the promotion of TRIM47 on the Warburg effect and pancreatic cancer progression was abolished by the overexpression of FBP1. Therefore, targeting TRIM47/FBP1 axis might provide a novel strategy to suppress the development of pancreatic cancer.
Elsevier